Tapewire

Nasdaq · USD

CERS

CERUS CORP

Export transactions ↓
Tapewire entity
5431
SEC CIK
0001020214
Parsed reports
373

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 2026015
Apr 202600
May 202602
Jun 202605
Jul 202601
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 12, 2020 Filed Aug 14, 2020 21:53 UTC
Moore CarolSVP Reg. & Quality
SaleCommon Stock 21,621 $6.88 $148,752.48
Disclosure

SEC source: 0001209191-20-046838 · doc4.xml · nonDerivative · entry 2

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,130

F1 · shares: Represents the number of shares required to be sold to cover commission and mandatory tax withholdings on the "sell to cover" transaction described above and does not represent a discretionary sale by the reporting person.

F2 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.85 to $6.93 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
August 12, 2020 Filed Aug 14, 2020 21:53 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionCommon Stock 30,000 $3.00 $90,000.00
Disclosure

SEC source: 0001209191-20-046838 · doc4.xml · nonDerivative · entry 1

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 01:15 UTC
Green Kevin DennisChief Financial Officer
Exercise / conversionOption (Right to Buy) · Derivative 80,000 Not disclosed Strike: $2.08 Not disclosed
Disclosure

SEC source: 0001209191-20-046258 · doc4.xml · derivative · entry 4

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires 2021-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: Not applicable.

F5 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 01:15 UTC
Green Kevin DennisChief Financial Officer
SaleCommon Stock 3,585 $6.99 $25,044.09
Disclosure

SEC source: 0001209191-20-046258 · doc4.xml · nonDerivative · entry 3

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,396

F1 · shares: This transaction was executed pursuant to a 10b5-1 plan.

F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.95 to $7.06 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 01:15 UTC
Green Kevin DennisChief Financial Officer
SaleCommon Stock 65,000 $6.96 $452,634.00
Disclosure

SEC source: 0001209191-20-046258 · doc4.xml · nonDerivative · entry 2

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,981

F2 · shares: This transaction was executed pursuant to a 10b5-1 plan. Represents the number of shares required to be sold to cover commission and mandatory tax withholdings on the "sell to cover" transaction described above and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 01:15 UTC
Green Kevin DennisChief Financial Officer
Exercise / conversionCommon Stock 80,000 $2.08 $166,400.00
Disclosure

SEC source: 0001209191-20-046258 · doc4.xml · nonDerivative · entry 1

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,981

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was executed pursuant to a 10b5-1 plan.

Read SEC document
August 07, 2020 Filed Aug 12, 2020 01:18 UTC
Jensen ChrystalChief Legal Officer
SaleCommon Stock 23,621 $7.07 $166,929.61
Disclosure

SEC source: 0001209191-20-046261 · doc4.xml · nonDerivative · entry 1

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,585

F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.15 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
August 07, 2020 Filed Aug 12, 2020 01:16 UTC Exercise / conversionOption (Right to Buy) · Derivative 43,800 Not disclosed Strike: $4.34 Not disclosed
Disclosure

SEC source: 0001209191-20-046259 · doc4.xml · derivative · entry 4

ANDERSON TIMOTHY B · CIK 0001124168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,800 shares

Expires 2024-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: Not applicable.

F5 · derivative.exercise_date: The option became exercisable in 12 equal monthly installments after the grant date.

Read SEC document
August 07, 2020 Filed Aug 12, 2020 01:16 UTC SaleCommon Stock 10,223 $7.10 $72,583.30
Disclosure

SEC source: 0001209191-20-046259 · doc4.xml · nonDerivative · entry 3

ANDERSON TIMOTHY B · CIK 0001124168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,406

F1 · shares: This transaction was executed pursuant to a 10b5-1 plan.

F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
August 07, 2020 Filed Aug 12, 2020 01:16 UTC SaleCommon Stock 29,853 $7.12 $212,568.29
Disclosure

SEC source: 0001209191-20-046259 · doc4.xml · nonDerivative · entry 2

ANDERSON TIMOTHY B · CIK 0001124168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,629

F2 · shares: This transaction was executed pursuant to a 10b5-1 plan. Represents the number of shares required to be sold to cover commission and mandatory tax withholdings on the "sell to cover" transaction described above and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
August 07, 2020 Filed Aug 12, 2020 01:16 UTC Exercise / conversionCommon Stock 43,800 $4.34 $190,092.00
Disclosure

SEC source: 0001209191-20-046259 · doc4.xml · nonDerivative · entry 1

ANDERSON TIMOTHY B · CIK 0001124168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was executed pursuant to a 10b5-1 plan.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionOption (Right to Buy) · Derivative 31,666 Not disclosed Strike: $4.32 Not disclosed
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · derivative · entry 9

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,750

Underlying: Common Stock · 31,666 shares

Expires 2028-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionOption (Right to Buy) · Derivative 22,917 Not disclosed Strike: $4.33 Not disclosed
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · derivative · entry 8

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 22,917 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionOption (Right to Buy) · Derivative 100,000 Not disclosed Strike: $4.72 Not disclosed
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · derivative · entry 7

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 100,000 shares

Expires 2025-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
SaleCommon Stock 31,666 $7.20 $228,004.70
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 6

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,763

F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported sale price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionCommon Stock 31,666 $4.32 $136,797.12
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 5

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,429

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
SaleCommon Stock 22,917 $7.20 $165,009.28
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 4

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,763

F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported sale price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionCommon Stock 22,917 $4.33 $99,230.61
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 3

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
SaleCommon Stock 100,000 $7.20 $720,030.00
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 2

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,763

F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported sale price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
July 07, 2020 Filed Jul 10, 2020 00:45 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionCommon Stock 100,000 $4.72 $472,000.00
Disclosure

SEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 1

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 25, 2020 Filed Jun 27, 2020 00:06 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionOption (Right to Buy) · Derivative 130,000 Not disclosed Strike: $2.08 Not disclosed
Disclosure

SEC source: 0001209191-20-039187 · doc4.xml · derivative · entry 3

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 130,000 shares

Expires 2021-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.

Read SEC document
June 25, 2020 Filed Jun 27, 2020 00:06 UTC
Moore CarolSVP Reg. & Quality
SaleCommon Stock 130,000 $7.00 $910,000.00
Disclosure

SEC source: 0001209191-20-039187 · doc4.xml · nonDerivative · entry 2

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,751

F1 · shares: This transaction was executed pursuant to a 10b5-1 plan.

Read SEC document
June 25, 2020 Filed Jun 27, 2020 00:06 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionCommon Stock 130,000 $2.08 $270,400.00
Disclosure

SEC source: 0001209191-20-039187 · doc4.xml · nonDerivative · entry 1

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was executed pursuant to a 10b5-1 plan.

Read SEC document
June 05, 2020 Filed Jun 10, 2020 00:00 UTC
Witney FrankDirector
Exercise / conversionRestricted Stock Unit · Derivative 11,184 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-035414 · doc4.xml · derivative · entry 2

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,184 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F3 · price: Not applicable.

F2 · derivative.exercise_date: This restricted stock unit vested one year from the date of grant.

F2 · derivative.expiration_date: This restricted stock unit vested one year from the date of grant.

Read SEC document
June 05, 2020 Filed Jun 10, 2020 00:00 UTC
Witney FrankDirector
Exercise / conversionCommon Stock 11,184 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-035414 · doc4.xml · nonDerivative · entry 1

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,489

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 23:58 UTC Exercise / conversionRestricted Stock Unit · Derivative 13,958 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-035413 · doc4.xml · derivative · entry 2

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,958 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F3 · price: Not applicable.

F2 · derivative.exercise_date: This restricted stock unit vested one year from the date of grant.

F2 · derivative.expiration_date: This restricted stock unit vested one year from the date of grant.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 23:58 UTC Exercise / conversionCommon Stock 13,958 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-035413 · doc4.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,868

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 23:57 UTC Exercise / conversionRestricted Stock Unit · Derivative 11,184 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-035412 · doc4.xml · derivative · entry 2

ANDERSON TIMOTHY B · CIK 0001124168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,184 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F3 · price: Not applicable.

F2 · derivative.exercise_date: This restricted stock unit vested one year from the date of grant.

F2 · derivative.expiration_date: This restricted stock unit vested one year from the date of grant.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 23:57 UTC Exercise / conversionCommon Stock 11,184 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-035412 · doc4.xml · nonDerivative · entry 1

ANDERSON TIMOTHY B · CIK 0001124168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 23:54 UTC
SCHULZE GAILDirector
Exercise / conversionRestricted Stock Unit · Derivative 11,184 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-035411 · doc4.xml · derivative · entry 2

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,184 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F4 · price: Not applicable.

F3 · derivative.exercise_date: This restricted stock unit vested one year from the date of grant.

F3 · derivative.expiration_date: This restricted stock unit vested one year from the date of grant.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 23:54 UTC
SCHULZE GAILDirector
Exercise / conversionCommon Stock 11,184 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-035411 · doc4.xml · nonDerivative · entry 1

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F2 · balance_after: Reflects 10,223 shares issued upon vesting of restricted stock unit on June 4, 2019 inadvertently omitted from Table I, Column 5 of Form 4 filed on December 6, 2019.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 23:03 UTC
Witney FrankDirector
GrantRestricted Stock Unit · Derivative 13,228 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-034846 · doc4.xml · derivative · entry 2

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,228

Underlying: Common Stock · 13,228 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F2 · price: Not applicable.

F4 · derivative.exercise_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

F4 · derivative.expiration_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 23:03 UTC
Witney FrankDirector
GrantOption (Right to Buy) · Derivative 28,177 Not disclosed Strike: $6.37 Not disclosed
Disclosure

SEC source: 0001209191-20-034846 · doc4.xml · derivative · entry 1

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,177

Underlying: Common Stock · 28,177 shares

Expires 2030-06-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 23:02 UTC GrantRestricted Stock Unit · Derivative 15,961 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-034845 · doc4.xml · derivative · entry 2

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,961

Underlying: Common Stock · 15,961 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F2 · price: Not applicable.

F4 · derivative.exercise_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

F4 · derivative.expiration_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 23:02 UTC GrantOption (Right to Buy) · Derivative 34,001 Not disclosed Strike: $6.37 Not disclosed
Disclosure

SEC source: 0001209191-20-034845 · doc4.xml · derivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,001

Underlying: Common Stock · 34,001 shares

Expires 2030-06-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 23:00 UTC
SCHULZE GAILDirector
GrantRestricted Stock Unit · Derivative 13,228 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-034842 · doc4.xml · derivative · entry 2

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,228

Underlying: Common Stock · 13,228 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F2 · price: Not applicable.

F4 · derivative.exercise_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

F4 · derivative.expiration_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 23:00 UTC
SCHULZE GAILDirector
GrantOption (Right to Buy) · Derivative 28,177 Not disclosed Strike: $6.37 Not disclosed
Disclosure

SEC source: 0001209191-20-034842 · doc4.xml · derivative · entry 1

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,177

Underlying: Common Stock · 28,177 shares

Expires 2030-06-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 22:55 UTC GrantRestricted Stock Unit · Derivative 13,228 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-034831 · doc4.xml · derivative · entry 2

NACHTSHEIM JAMI K · CIK 0001223017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,228

Underlying: Common Stock · 13,228 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F2 · price: Not applicable.

F4 · derivative.exercise_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

F4 · derivative.expiration_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 22:55 UTC GrantOption (Right to Buy) · Derivative 28,177 Not disclosed Strike: $6.37 Not disclosed
Disclosure

SEC source: 0001209191-20-034831 · doc4.xml · derivative · entry 1

NACHTSHEIM JAMI K · CIK 0001223017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,177

Underlying: Common Stock · 28,177 shares

Expires 2030-06-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 22:50 UTC GrantRestricted Stock Unit · Derivative 13,228 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-034821 · doc4.xml · derivative · entry 2

MOORE TIMOTHY L. · CIK 0001669207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,228

Underlying: Common Stock · 13,228 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F2 · price: Not applicable.

F4 · derivative.exercise_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

F4 · derivative.expiration_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 22:50 UTC GrantOption (Right to Buy) · Derivative 28,177 Not disclosed Strike: $6.37 Not disclosed
Disclosure

SEC source: 0001209191-20-034821 · doc4.xml · derivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,177

Underlying: Common Stock · 28,177 shares

Expires 2030-06-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 22:47 UTC GrantRestricted Stock Unit · Derivative 13,228 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-034813 · doc4.xml · derivative · entry 2

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,228

Underlying: Common Stock · 13,228 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F2 · price: Not applicable.

F4 · derivative.exercise_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

F4 · derivative.expiration_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 22:47 UTC GrantOption (Right to Buy) · Derivative 28,177 Not disclosed Strike: $6.37 Not disclosed
Disclosure

SEC source: 0001209191-20-034813 · doc4.xml · derivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,177

Underlying: Common Stock · 28,177 shares

Expires 2030-06-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 22:43 UTC GrantRestricted Stock Unit · Derivative 13,228 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-034805 · doc4.xml · derivative · entry 2

ANDERSON TIMOTHY B · CIK 0001124168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,228

Underlying: Common Stock · 13,228 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F2 · price: Not applicable.

F4 · derivative.exercise_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

F4 · derivative.expiration_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 22:43 UTC GrantOption (Right to Buy) · Derivative 28,177 Not disclosed Strike: $6.37 Not disclosed
Disclosure

SEC source: 0001209191-20-034805 · doc4.xml · derivative · entry 1

ANDERSON TIMOTHY B · CIK 0001124168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,177

Underlying: Common Stock · 28,177 shares

Expires 2030-06-02

F2 · price: Not applicable.

F1 · derivative.exercise_date: The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders.

Read SEC document
June 01, 2020 Filed Jun 4, 2020 01:40 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionOption (Right to Buy) · Derivative 25 Not disclosed Strike: $2.48 Not disclosed
Disclosure

SEC source: 0001209191-20-034334 · doc4.xml · derivative · entry 6

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25 shares

Expires 2021-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.

Read SEC document
June 01, 2020 Filed Jun 4, 2020 01:40 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionOption (Right to Buy) · Derivative 30,000 Not disclosed Strike: $3.00 Not disclosed
Disclosure

SEC source: 0001209191-20-034334 · doc4.xml · derivative · entry 5

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2020-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.

Read SEC document
June 01, 2020 Filed Jun 4, 2020 01:40 UTC
Moore CarolSVP Reg. & Quality
SaleCommon Stock 25 $6.50 $162.50
Disclosure

SEC source: 0001209191-20-034334 · doc4.xml · nonDerivative · entry 4

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,751

F1 · shares: This transaction was executed pursuant to a 10b5-1 plan.

Read SEC document
June 01, 2020 Filed Jun 4, 2020 01:40 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionCommon Stock 25 $2.28 $57.00
Disclosure

SEC source: 0001209191-20-034334 · doc4.xml · nonDerivative · entry 3

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,776

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2020 Filed Jun 4, 2020 01:40 UTC
Moore CarolSVP Reg. & Quality
SaleCommon Stock 30,000 $6.50 $195,000.00
Disclosure

SEC source: 0001209191-20-034334 · doc4.xml · nonDerivative · entry 2

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,751

F1 · shares: This transaction was executed pursuant to a 10b5-1 plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.